Oxidative stress and mitochondrial defect in neuromuscular disorders: Source or symptoms?

Oxidative Stress: Causes, Role in Diseases and Biological Effects

Volumn , Issue , 2014, Pages 1-60

  Cornelius, Nanna ^a   Gregersen, Niels ^b   Tümer, Zeynep ^a   Olsen, Rikke K J ^b  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84954590660     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (281)

1. Lin, M.T., Beal, M.F. (2006) Mitochondrial Dysfunction And Oxidative Stress In Neurodegenerative Diseases. Nature, 443, 787-795.
2. Circu, M.L., Aw, T.Y. (2010) Reactive Oxygen Species, Cellular Redox Systems, And Apoptosis. Free Radic. Biol. Med., 48, 749-762.
3. Echtay, K.S. (2007) Mitochondrial Uncoupling Proteins--What Is Their Physiological Role? Free Radic. Biol. Med., 43, 1351-1371.
4. St-Pierre, J., Buckingham, J.A., Roebuck, S.J., Brand, M.D. (2002) Topology Of Superoxide Production From Different Sites In The Mitochondrial Electron Transport Chain. J Biol. Chem, 277, 44784- 44790.
5. Drose, S., Brandt, U. (2012) Molecular Mechanisms Of Superoxide Production By The Mitochondrial Respiratory Chain. Adv. Exp. Med. Biol., 748, 145-169.
6. Chance, B., Sies, H., Boveris, A. (1979) Hydroperoxide Metabolism In Mammalian Organs. Physiol Rev., 59, 527-605.
7. Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T., Mazur, M., Telser, J. (2007) Free Radicals And Antioxidants In Normal Physiological Functions And Human Disease. Int. J Biochem. Cell Biol., 39, 44-84.
8. Jezek, P., Hlavata, L. (2005) Mitochondria In Homeostasis Of Reactive Oxygen Species In Cell, Tissues, And Organism. Int. J Biochem. Cell Biol., 37, 2478-2503.
9. Olsen, R.K., Cornelius, N., Gregersen, N. (2013) Genetic And Cellular Modifiers Of Oxidative Stress: What Can We Learn From Fatty Acid Oxidation Defects? Mol. Genet. Metab, 110 Suppl, S31-S39.
10. Cup, E.H., Pieterse, A.J., Ten Broek-Pastoor, J.M., Munneke, M., Van Engelen, B.G., Hendricks, H.T., Van Der Wilt, G.J., Oostendorp, R.A. (2007) Exercise Therapy And Other Types Of Physical Therapy For Patients With Neuromuscular Diseases: A Systematic Review. Arch. Phys. Med. Rehabil., 88, 1452-1464.
11. Sadeghian, H., Wolfe, G.I. (2010) Therapy Update In Nerve, Neuromuscular Junction And Myopathic Disorders. Curr. Opin. Neurol., 23, 496-501.
12. Gomes, C.M., Santos, R. (2013) Neurodegeneration In Friedreich's Ataxia: From Defective Frataxin To Oxidative Stress. Oxid. Med. Cell Longev., 2013, 487534.
13. Berg, J.M., Tymoczko, J.L., Stryer, L. (2002) Biochemistry. W.H. Freeman, New York.
14. Mcbride, H.M., Neuspiel, M., Wasiak, S. (2006) Mitochondria: More Than Just A Powerhouse. Curr. Biol., 16, R551-R560.
15. Fischer, F., Hamann, A., Osiewacz, H.D. (2012) Mitochondrial Quality Control: An Integrated Network Of Pathways. Trends Biochem. Sci., 37, 284-292.
16. Ray, P.D., Huang, B.W., Tsuji, Y. (2012) Reactive Oxygen Species (ROS) Homeostasis And Redox Regulation In Cellular Signaling. Cell Signal., 24, 981-990.
17. Martindale, J.L., Holbrook, N.J. (2002) Cellular Response To Oxidative Stress: Signaling For Suicide And Survival. J. Cell Physiol, 192, 1-15.
18. Murphy, M.P. (2009) How Mitochondria Produce Reactive Oxygen Species. Biochem. J, 417, 1-13.
19. Mates, J.M. (2000) Effects Of Antioxidant Enzymes In The Molecular Control Of Reactive Oxygen Species Toxicology. Toxicology, 153, 83- 104.
20. Andreyev, A.Y., Kushnareva,Y.E., Starkov, A.A. (2005) Mitochondrial Metabolism Of Reactive Oxygen Species. Biochemistry (Mosc.), 70, 200-214.
21. Starkov, A.A., Fiskum, G., Chinopoulos, C., Lorenzo, B.J., Browne, S.E., Patel, M.S., Beal, M.F. (2004) Mitochondrial Alpha-Ketoglutarate Dehydrogenase Complex Generates Reactive Oxygen Species. J. Neurosci., 24, 7779-7788.
22. Tretter, L., Takacs, K., Hegedus, V., Adam-Vizi, V. (2007) Characteristics Of Alpha-Glycerophosphate-Evoked H2O2 Generation In Brain Mitochondria. J. Neurochem., 100, 650-663.
23. Cornelius, N., Byron, C., Hargreaves, I., Guerra, P.F., Furdek, A.K., Land, J., Radford, W.W., Frerman, F., Corydon, T.J., Gregersen, N., Olsen, R.K. (2013) Secondary Coenzyme Q10 Deficiency And Oxidative Stress In Cultured Fibroblasts From Patients With Riboflavin Responsive Multiple Acyl-Coa Dehydrogenation Deficiency. Hum. Mol. Genet., 22, 3819-3827.
24. Rodrigues, J.V., Gomes, C.M. (2012) Mechanism Of Superoxide And Hydrogen Peroxide Generation By Human Electron-Transfer Flavoprotein And Pathological Variants. Free Radic. Biol. Med., 53, 12- 19.
25. Zeevalk, G.D., Bernard, L.P., Song, C., Gluck, M., Ehrhart, J. (2005) Mitochondrial Inhibition And Oxidative Stress: Reciprocating Players In Neurodegeneration. Antioxid. Redox. Signal., 7, 1117-1139.
26. Otterbein, L.E., Soares, M.P., Yamashita, K., Bach, F.H. (2003) Heme Oxygenase-1: Unleashing The Protective Properties Of Heme. Trends Immunol., 24, 449-455.
27. Bentinger, M., Brismar, K., Dallner, G. (2007) The Antioxidant Role Of Coenzyme Q. Mitochondrion., 7 Suppl, S41-S50.
28. Quinzii, C.M., Hirano, M. (2011) Primary And Secondary Coq(10) Deficiencies In Humans. Biofactors, 37, 361-365.
29. Quinzii, C.M., Lopez, L.C., Naini, A., Dimauro, S., Hirano, M. (2008) Human Coq10 Deficiencies. Biofactors, 32, 113-118.
30. Manthey, K.C., Chew, Y.C., Zempleni, J. (2005) Riboflavin Deficiency Impairs Oxidative Folding And Secretion Of Apolipoprotein B-100 In Hepg2 Cells, Triggering Stress Response Systems. J Nutr., 135, 978- 982.
31. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., Yamamoto, M. (1999) Keap1 Represses Nuclear Activation Of Antioxidant Responsive Elements By Nrf2 Through Binding To The Amino-Terminal Neh2 Domain. Genes Dev., 13, 76-86.
32. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., Yamamoto, M. (2004) Oxidative Stress Sensor Keap1 Functions As An Adaptor For Cul3-Based E3 Ligase To Regulate Proteasomal Degradation Of Nrf2. Mol. Cell Biol., 24, 7130-7139.
33. Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H., Yamamoto, M. (2008) Physiological Significance Of Reactive Cysteine Residues Of Keap1 In Determining Nrf2 Activity. Mol. Cell Biol., 28, 2758-2770.
34. Sekhar, K.R., Rachakonda, G., Freeman, M.L. (2010) Cysteine-Based Regulation Of The CUL3 Adaptor Protein Keap1. Toxicol. Appl. Pharmacol., 244, 21-26.
35. Ma, Q. (2013) Role Of Nrf2 In Oxidative Stress And Toxicity. Annu. Rev. Pharmacol. Toxicol., 53, 401-426.
36. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) An Nrf2/Small Maf Heterodimer Mediates The Induction Of Phase II Detoxifying Enzyme Genes Through Antioxidant Response Elements. Biochem. Biophys. Res. Commun., 236, 313-322.
37. Seppet, E., Gruno, M., Peetsalu, A., Gizatullina, Z., Nguyen, H.P., Vielhaber, S., Wussling, M.H., Trumbeckaite, S., Arandarcikaite, O., Jerzembeck, D., et al. (2009) Mitochondria And Energetic Depression In Cell Pathophysiology. Int. J. Mol. Sci., 10, 2252-2303.
38. Kant, R., Bali, A., Singh, N., Jaggi, A.S. (2013) Prolyl 4 Hydroxylase: A Critical Target In The Pathophysiology Of Diseases. Korean J. Physiol Pharmacol., 17, 111-120.
39. Fogg, V.C., Lanning, N.J., Mackeigan, J.P. (2011) Mitochondria In Cancer: At The Crossroads Of Life And Death. Chin J Cancer, 30, 526- 539.
40. Semenza, G.L. (2010) HIF-1: Upstream And Downstream Of Cancer Metabolism. Curr. Opin. Genet Dev., 20, 51-56.
41. Semenza, G.L. (2010) Defining The Role Of Hypoxia-Inducible Factor 1 In Cancer Biology And Therapeutics. Oncogene, 29, 625-634.
42. WARBURG, O. (1956) On The Origin Of Cancer Cells. Science, 123, 309-314.
43. Smolkova, K., Plecita-Hlavata, L., Bellance, N., Benard, G., Rossignol, R., Jezek, P. (2011) Waves Of Gene Regulation Suppress And Then Restore Oxidative Phosphorylation In Cancer Cells. Int. J Biochem. Cell Biol., 43, 950-968.
44. Guppy, M. (2002) The Hypoxic Core: A Possible Answer To The Cancer Paradox. Biochem. Biophys. Res. Commun., 299, 676-680.
45. Altenberg, B., Greulich,K.O. (2004) Genes Of Glycolysis Are Ubiquitously Overexpressed In 24 Cancer Classes. Genomics, 84, 1014- 1020.
46. Bonnet, S., Archer, S.L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C.T., Lopaschuk, G.D., Puttagunta, L., Bonnet, S., et al. (2007) A Mitochondria-K+ Channel Axis Is Suppressed In Cancer And Its Normalization Promotes Apoptosis And Inhibits Cancer Growth. Cancer Cell, 11, 37-51.
47. Xie, H., Valera, V.A., Merino, M.J., Amato, A.M., Signoretti, S., Linehan, W.M., Sukhatme, V.P., Seth, P. (2009) LDH-A Inhibition, A Therapeutic Strategy For Treatment Of Hereditary Leiomyomatosis And Renal Cell Cancer. Mol. Cancer Ther., 8, 626-635.
48. Hatzivassiliou, G., Zhao, F., Bauer, D.E., Andreadis, C., Shaw, A.N., Dhanak, D., Hingorani, S.R., Tuveson, D.A., Thompson, C.B. (2005) ATP Citrate Lyase Inhibition Can Suppress Tumor Cell Growth. Cancer Cell, 8, 311-321.
49. Koppenol, W.H., Bounds, P.L., Dang, C.V. (2011) Otto Warburg's Contributions To Current Concepts Of Cancer Metabolism. Nat. Rev. Cancer, 11, 325-337.
50. Lopez-Lazaro, M. (2008) The Warburg Effect: Why And How Do Cancer Cells Activate Glycolysis In The Presence Of Oxygen? Anticancer Agents Med. Chem, 8, 305-312.
51. Moreno-Sanchez, R., Rodriguez-Enriquez, S., Marin-Hernandez, A., Saavedra, E. (2007) Energy Metabolism In Tumor Cells. FEBS J, 274, 1393-1418.
52. Gatenby, R.A., Gillies, R.J. (2004) Why Do Cancers Have High Aerobic Glycolysis? Nat. Rev. Cancer, 4, 891-899.
53. Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R.G., Chiavarina, B., Frank, P.G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U.E., et al. (2010) Ketones And Lactate "Fuel" Tumor Growth And Metastasis: Evidence That Epithelial Cancer Cells Use Oxidative Mitochondrial Metabolism. Cell Cycle, 9, 3506-3514.
54. Hirschhaeuser, F., Sattler, U.G., Mueller-Klieser, W. (2011) Lactate: A Metabolic Key Player In Cancer. Cancer Res., 71, 6921-6925.
55. Vaughn, A.E., Deshmukh, M. (2008) Glucose Metabolism Inhibits Apoptosis In Neurons And Cancer Cells By Redox Inactivation Of Cytochrome C. Nat. Cell Biol., 10, 1477-1483.
56. Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C., Schumacker, P.T. (1998) Mitochondrial Reactive Oxygen Species Trigger Hypoxia-Induced Transcription. Proc. Natl. Acad. Sci. U. S. A, 95, 11715-11720.
57. Mansfield, K.D., Guzy, R.D., Pan, Y., Young, R.M., Cash, T.P., Schumacker, P.T., Simon, M.C. (2005) Mitochondrial Dysfunction Resulting From Loss Of Cytochrome C Impairs Cellular Oxygen Sensing And Hypoxic HIF-Alpha Activation. Cell Metab, 1, 393-399.
58. Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Hammerling, U., Schumacker, P.T. (2005) Mitochondrial Complex III Is Required For Hypoxia-Induced ROS Production And Cellular Oxygen Sensing. Cell Metab, 1, 401-408.
59. Brunelle, J.K., Bell, E.L., Quesada, N.M., Vercauteren, K., Tiranti,V., Zeviani, M., Scarpulla, R.C., Chandel, N.S. (2005) Oxygen Sensing Requires Mitochondrial ROS But Not Oxidative Phosphorylation. Cell Metab, 1, 409-414.
60. Kaelin, W.G., Jr. (2005) ROS: Really Involved In Oxygen Sensing. Cell Metab, 1, 357-358.
61. Ma, Q., Cavallin, L.E., Yan, B., Zhu, S., Duran, E.M., Wang, H., Hale, L.P., Dong, C., Cesarman, E., Mesri, E.A., Goldschmidt-Clermont,P.J. (2009) Antitumorigenesis Of Antioxidants In A Transgenic Rac1 Model Of Kaposi's Sarcoma. Proc. Natl. Acad. Sci. U. S. A, 106, 8683-8688.
62. Guzy, R.D., Sharma, B., Bell, E., Chandel, N.S., Schumacker, P.T. (2008) Loss Of The Sdhb, But Not The Sdha, Subunit Of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation And Tumorigenesis. Mol. Cell Biol., 28, 718-731.
63. Yuan, H.X., Xiong, Y., Guan, K.L. (2013) Nutrient Sensing, Metabolism, And Cell Growth Control. Mol. Cell, 49, 379-387.
64. Hagen, T. (2012) Oxygen Versus Reactive Oxygen In The Regulation Of HIF-1alpha: The Balance Tips. Biochem. Res. Int., 2012, 436981.
65. Page, E.L., Chan, D.A., Giaccia, A.J., Levine, M., Richard, D.E. (2008) Hypoxia-Inducible Factor-1alpha Stabilization In Nonhypoxic Conditions: Role Of Oxidation And Intracellular Ascorbate Depletion. Mol. Biol. Cell, 19, 86-94.
66. Finkel, T. (2012) Signal Transduction By Mitochondrial Oxidants. J. Biol. Chem., 287, 4434-4440.
67. Huang, C., Han, Y., Wang, Y., Sun, X., Yan, S., Yeh, E.T., Chen, Y., Cang, H., Li, H., Shi, G., et al. (2009) SENP3 Is Responsible For HIF-1 Transactivation Under Mild Oxidative Stress Via P300 De-Sumoylation. EMBO J., 28, 2748-2762.
68. Wang, Y., Yang, J., Yang, K., Cang, H., Huang, X.Z., Li, H., Yi, J. (2012) The Biphasic Redox Sensing Of SENP3 Accounts For The HIF-1 Transcriptional Activity Shift By Oxidative Stress. Acta Pharmacol. Sin., 33, 953-963.
69. Fijalkowska, I., Xu, W., Comhair, S.A., Janocha, A.J., Mavrakis, L.A., Krishnamachary, B., Zhen, L., Mao, T., Richter, A., Erzurum, S.C., Tuder, R.M. (2010) Hypoxia Inducible-Factor1alpha Regulates The Metabolic Shift Of Pulmonary Hypertensive Endothelial Cells. Am. J Pathol., 176, 1130-1138.
70. Sasabe, E., Yang, Z., Ohno, S., Yamamoto, T. (2010) Reactive Oxygen Species Produced By The Knockdown Of Manganese-Superoxide Dismutase Up-Regulate Hypoxia-Inducible Factor-1alpha Expression In Oral Squamous Cell Carcinoma Cells. Free Radic. Biol. Med., 48, 1321- 1329.
71. Kaewpila, S., Venkataraman, S., Buettner, G.R., Oberley, L.W. (2008) Manganese Superoxide Dismutase Modulates Hypoxia-Inducible Factor- 1 Alpha Induction Via Superoxide. Cancer Res., 68, 2781-2788.
72. Shaw, P.J. (2005) Molecular And Cellular Pathways Of Neurodegeneration In Motor Neurone Disease. J. Neurol. Neurosurg. Psychiatry, 76, 1046-1057.
73. Shaw, P.J. (1999) Motor Neurone Disease. BMJ, 318, 1118-1121.
74. Gandhi, S., Abramov, A.Y. (2012) Mechanism Of Oxidative Stress In Neurodegeneration. Oxid. Med. Cell Longev., 2012, 428010.
75. Kann, O., Kovacs, R. (2007) Mitochondria And Neuronal Activity. Am. J. Physiol Cell Physiol, 292, C641-C657.
76. Shaw, P.J., Eggett, C.J. (2000) Molecular Factors Underlying Selective Vulnerability Of Motor Neurons To Neurodegeneration In Amyotrophic Lateral Sclerosis. J. Neurol., 247 Suppl 1, I17-I27.
77. Berridge, M.J. (1998) Neuronal Calcium Signaling. Neuron, 21, 13-26.
78. Bilsland, L.G., Sahai, E., Kelly, G., Golding, M., Greensmith, L., Schiavo, G. (2010) Deficits In Axonal Transport Precede ALS Symptoms In Vivo. Proc. Natl. Acad. Sci. U. S. A, 107, 20523-20528.
79. Williamson, T.L., Cleveland, D.W. (1999) Slowing Of Axonal Transport Is A Very Early Event In The Toxicity Of ALS-Linked SOD1 Mutants To Motor Neurons. Nat. Neurosci., 2, 50-56.
80. Saha, A.R., Hill, J., Utton, M.A., Asuni, A.A., Ackerley, S., Grierson, A.J., Miller, C.C., Davies, A.M., Buchman, V.L., Anderton, B.H., Hanger, D.P. (2004) Parkinson's Disease Alpha-Synuclein Mutations Exhibit Defective Axonal Transport In Cultured Neurons. J. Cell Sci., 117, 1017-1024.
81. Trimmer, P.A., Schwartz, K.M., Borland, M.K., De, T.L., Streeter, J., Oron, U. (2009) Reduced Axonal Transport In Parkinson's Disease Cybrid Neurites Is Restored By Light Therapy. Mol. Neurodegener., 4, 26.
82. Utton, M.A., Noble, W.J., Hill, J.E., Anderton, B.H., Hanger, D.P. (2005) Molecular Motors Implicated In The Axonal Transport Of Tau And Alpha-Synuclein. J. Cell Sci., 118, 4645-4654.
83. Her, L.S., Goldstein, L.S. (2008) Enhanced Sensitivity Of Striatal Neurons To Axonal Transport Defects Induced By Mutant Huntingtin. J. Neurosci., 28, 13662-13672.
84. Fang, C., Bourdette, D., Banker, G. (2012) Oxidative Stress Inhibits Axonal Transport: Implications For Neurodegenerative Diseases. Mol. Neurodegener., 7, 29.
85. Shidara, Y., Hollenbeck, P.J. (2010) Defects In Mitochondrial Axonal Transport And Membrane Potential Without Increased Reactive Oxygen Species Production In A Drosophila Model Of Friedreich Ataxia. J. Neurosci., 30, 11369-11378.
86. Tobon, A. (2013) Metabolic Myopathies. Continuum (Minneap. Minn.), 19, 1571-1597.
87. Koopman, W.J., Distelmaier, F., Smeitink, J.A., Willems, P.H. (2013) OXPHOS Mutations And Neurodegeneration. EMBO J, 32, 9-29.
88. Koopman, W.J., Willems, P.H., Smeitink, J.A. (2012) Monogenic Mitochondrial Disorders. N. Engl. J Med., 366, 1132-1141.
89. Wei, Y.H., Lee, H.C. (2003) Mitochondrial DNA Mutations And Oxidative Stress In Mitochondrial Diseases. Adv. Clin. Chem., 37, 83- 128.
90. Olsen, R.K., Cornelius, N., Gregersen, N. (2013) Genetic And Cellular Modifiers Of Oxidative Stress: What Can We Learn From Fatty Acid Oxidation Defects? Mol Genet Metab, 110 Suppl, S31-S39.
91. Gregersen, N., Andresen, B.S., Pedersen, C.B., Olsen, R.K., Corydon, T.J., Bross, P. (2008) Mitochondrial Fatty Acid Oxidation Defects-- Remaining Challenges. J Inherit. Metab Dis, 31, 643-657.
92. Gregersen, N., Olsen, R.K. (2010) Disease Mechanisms And Protein Structures In Fatty Acid Oxidation Defects. J Inherit. Metab Dis, 33, 547-553.
93. Wajner, M., Goodman, S.I. (2011) Disruption Of Mitochondrial Homeostasis In Organic Acidurias: Insights From Human And Animal Studies. J Bioenerg. Biomembr., 43, 31-38.
94. Kolker, S., Burgard, P., Sauer, S.W., Okun, J.G. (2013) Current Concepts In Organic Acidurias: Understanding Intra- And Extracerebral Disease Manifestation. J Inherit. Metab Dis, 36, 635-644.
95. Ribas, G.S., Vargas, C.R., Wajner, M. (2014) L-Carnitine Supplementation As A Potential Antioxidant Therapy For Inherited Neurometabolic Disorders. Gene, 533, 469-476.
96. Tein, I. (1999) Neonatal Metabolic Myopathies. Semin. Perinatol., 23, 125-151.
97. Laforet, P., Vianey-Saban, C. (2010) Disorders Of Muscle Lipid Metabolism: Diagnostic And Therapeutic Challenges. Neuromuscul. Disord., 20, 693-700.
98. Wu, S.B., Wei, Y.H. (2012) AMPK-Mediated Increase Of Glycolysis As An Adaptive Response To Oxidative Stress In Human Cells: Implication Of The Cell Survival In Mitochondrial Diseases. Biochim. Biophys. Acta, 1822, 233-247.
99. Wu, S.B., Ma, Y.S., Wu, Y.T., Chen, Y.C., Wei, Y.H. (2010) Mitochondrial DNA Mutation-Elicited Oxidative Stress, Oxidative Damage, And Altered Gene Expression In Cultured Cells Of Patients With MERRF Syndrome. Mol Neurobiol., 41, 256-266.
100. Andresen, B.S., Olpin, S., Poorthuis, B.J., Scholte, H.R., Vianey-Saban, C., Wanders, R., Ijlst, L., Morris, A., Pourfarzam,M., Bartlett,K., et al. (1999) Clear Correlation Of Genotype With Disease Phenotype In Very- Long-Chain Acyl-Coa Dehydrogenase Deficiency. Am. J Hum Genet, 64, 479-494.
101. Olsen, R.K., Andresen, B.S., Christensen, E., Bross, P., Skovby, F., Gregersen, N. (2003) Clear Relationship Between ETF/ETFDH Genotype And Phenotype In Patients With Multiple Acyl-Coa Dehydrogenation Deficiency. Hum Mutat., 22, 12-23.
102. Gregersen, N., Andresen, B.S., Corydon, M.J., Corydon, T.J., Olsen, R.K., Bolund, L., Bross, P. (2001) Mutation Analysis In Mitochondrial Fatty Acid Oxidation Defects: Exemplified By Acyl-Coa Dehydrogenase Deficiencies, With Special Focus On Genotype- Phenotype Relationship. Hum Mutat., 18, 169-189.
103. Gregersen, N., Bross, P., Andresen, B.S. (2004) Genetic Defects In Fatty Acid Beta-Oxidation And Acyl-Coa Dehydrogenases. Molecular Pathogenesis And Genotype-Phenotype Relationships. Eur. J Biochem., 271, 470-482.
104. Bonnefont, J.P., Djouadi, F., Prip-Buus, C., Gobin, S., Munnich, A., Bastin, J. (2004) Carnitine Palmitoyltransferases 1 And 2: Biochemical, Molecular And Medical Aspects. Mol Aspects Med., 25, 495-520.
105. Spiekerkoetter, U. (2010) Mitochondrial Fatty Acid Oxidation Disorders: Clinical Presentation Of Long-Chain Fatty Acid Oxidation Defects Before And After Newborn Screening. J Inherit. Metab Dis, 33, 527-532.
106. Pedersen, C.B., Kolvraa, S., Kolvraa, A., Stenbroen, V., Kjeldsen, M., Ensenauer, R., Tein, I., Matern, D., Rinaldo, P., Vianey-Saban, C., et al. (2008) The ACADS Gene Variation Spectrum In 114 Patients With Short-Chain Acyl-Coa Dehydrogenase (SCAD) Deficiency Is Dominated By Missense Variations Leading To Protein Misfolding At The Cellular Level. Hum Genet, 124, 43-56.
107. Pedersen, C.B., Zolkipli, Z., Vang, S., Palmfeldt, J., Kjeldsen, M., Stenbroen, V., Schmidt, S.P., Wanders, R.J., Ruiter, J.P., Wibrand, F., et al. (2010) Antioxidant Dysfunction: Potential Risk For Neurotoxicity In Ethylmalonic Aciduria. J Inherit. Metab Dis, 33, 211-222.
108. Schmidt, S.P., Corydon, T.J., Pedersen, C.B., Vang, S., Palmfeldt, J., Stenbroen, V., Wanders, R.J., Ruiter, J.P., Gregersen, N. (2011) Toxic Response Caused By A Misfolding Variant Of The Mitochondrial Protein Short-Chain Acyl-Coa Dehydrogenase. J Inherit. Metab Dis, 34, 465-475.
109. Rocha, H., Ferreira, R., Carvalho, J., Vitorino, R., Santa, C., Lopes, L., Gregersen, N., Vilarinho, L., Amado, F. (2011) Characterization Of Mitochondrial Proteome In A Severe Case Of ETF-QO Deficiency. J Proteomics., 75, 221-228.
110. Edhager, A.V., Stenbroen, V., Nielsen, N.S., Bross, P., Olsen, R.K.J., Gregersen, N., Palmfeldt,J. (2014).
111. Schmidt, S.P., Corydon, T.J., Pedersen, C.B., Bross, P., Gregersen, N. (2010) Misfolding Of Short-Chain Acyl-Coa Dehydrogenase Leads To Mitochondrial Fission And Oxidative Stress. Mol Genet Metab, 100, 155-162.
112. Rodrigues, J.V., Gomes, C.M. (2012) Mechanism Of Superoxide And Hydrogen Peroxide Generation By Human Electron-Transfer Flavoprotein And Pathological Variants. Free Radic. Biol. Med., 53, 12- 19.
113. Cornelius, N., Frerman, F.E., Corydon, T.J., Palmfeldt, J., Bross, P., Gregersen, N., Olsen, R.K. (2012) Molecular Mechanisms Of Riboflavin Responsiveness In Patients With ETF-QO Variations And Multiple Acyl-Coa Dehydrogenation Deficiency. Hum Mol Genet, 21, 3435-3448.
114. Cornelius, N., Byron, C., Hargreaves, I., Guerra, P.F., Furdek, A.K., Land, J., Radford, W.W., Frerman, F., Corydon, T.J., Gregersen, N., Olsen, R.K. (2013) Secondary Coenzyme Q10 Deficiency And Oxidative Stress In Cultured Fibroblasts From Patients With Riboflavin Responsive Multiple Acyl-Coa Dehydrogenation Deficiency. Hum Mol Genet.
115. Schmidt, S.P., Corydon, T.J., Pedersen, C.B., Bross, P., Gregersen, N. (2010) Misfolding Of Short-Chain Acyl-Coa Dehydrogenase Leads To Mitochondrial Fission And Oxidative Stress. Mol Genet Metab, 100, 155-162.
116. Ashrafi, G., Schwarz, T.L. (2013) The Pathways Of Mitophagy For Quality Control And Clearance Of Mitochondria. Cell Death. Differ., 20, 31-42.
117. Gempel, K., Topaloglu, H., Talim, B., Schneiderat, P., Schoser, B.G., Hans, V.H., Palmafy, B., Kale, G., Tokatli, A., Quinzii, C., et al. (2007) The Myopathic Form Of Coenzyme Q10 Deficiency Is Caused By Mutations In The Electron-Transferring-Flavoprotein Dehydrogenase (ETFDH) Gene. Brain, 130, 2037-2044.
118. Olsen, R.K., Olpin, S.E., Andresen, B.S., Miedzybrodzka, Z.H., Pourfarzam, M., Merinero, B., Frerman, F.E., Beresford, M.W., Dean, J.C., Cornelius, N., et al. (2007) ETFDH Mutations As A Major Cause Of Riboflavin-Responsive Multiple Acyl-Coa Dehydrogenation Deficiency. Brain, 130, 2045-2054.
119. Wolfe, L.A., He, M., Vockley, J., Payne, N., Rhead, W., Hoppel, C., Spector, E., Gernert, K., Gibson, K.M. (2010) Novel ETF Dehydrogenase Mutations In A Patient With Mild Glutaric Aciduria Type II And Complex II-III Deficiency In Liver And Muscle. J Inherit. Metab Dis.
120. Wen, B., Dai, T., Li, W., Zhao, Y., Liu, S., Zhang, C., Li, H., Wu, J., Li, D., Yan, C. (2010) Riboflavin-Responsive Lipid-Storage Myopathy Caused By ETFDH Gene Mutations. J Neurol. Neurosurg. Psychiatry, 81, 231-236.
121. Wen, B., Li, D., Shan, J., Liu, S., Li, W., Zhao, Y., Lin, P., Zheng, J., Li, D., Gong, Y., Yan, C. (2013) Increased Muscle Coenzyme Q10 In Riboflavin Responsive MADD With ETFDH Gene Mutations Due To Secondary Mitochondrial Proliferation. Mol Genet Metab, 109, 154-160.
122. Liang, W.C., Ohkuma, A., Hayashi, Y.K., Lopez, L.C., Hirano, M., Nonaka, I., Noguchi, S., Chen, L.H., Jong, Y.J., Nishino, I. (2009) ETFDH Mutations, Coq10 Levels, And Respiratory Chain Activities In Patients With Riboflavin-Responsive Multiple Acyl-Coa Dehydrogenase Deficiency. Neuromuscul. Disord., 19, 212-216.
123. Tyni, T., Majander, A., Kalimo, H., Rapola, J., Pihko, H. (1996) Pathology Of Skeletal Muscle And Impaired Respiratory Chain Function In Long-Chain 3-Hydroxyacyl-Coa Dehydrogenase Deficiency With The G1528C Mutation. Neuromuscul. Disord., 6, 327-337.
124. Bujan, N., Arias, A., Montero, R., Garcia-Villoria, J., Lissens, W., Seneca, S., Espinos, C., Navas, P., De, M.L., Artuch, R., et al. (2014) Characterization Of Coq10 Biosynthesis In Fibroblasts Of Patients With Primary And Secondary Coq10 Deficiency. J Inherit. Metab Dis, 37, 53- 62.
125. Tonin, A.M., Ferreira, G.C., Grings, M., Viegas, C.M., Busanello, E.N., Amaral, A.U., Zanatta, A., Schuck, P.F., Wajner, M. (2010) Disturbance Of Mitochondrial Energy Homeostasis Caused By The Metabolites Accumulating In LCHAD And MTP Deficiencies In Rat Brain. Life Sci., 86, 825-831.
126. Tonin, A.M., Amaral, A.U., Busanello, E.N., Grings, M., Castilho, R.F., Wajner, M. (2013) Long-Chain 3-Hydroxy Fatty Acids Accumulating In Long-Chain 3-Hydroxyacyl-Coa Dehydrogenase And Mitochondrial Trifunctional Protein Deficiencies Uncouple Oxidative Phosphorylation In Heart Mitochondria. J Bioenerg. Biomembr., 45, 47-57.
127. Scaini, G., Simon, K.R., Tonin, A.M., Busanello, E.N., Moura, A.P., Ferreira, G.C., Wajner, M., Streck, E.L., Schuck, P.F. (2012) Toxicity Of Octanoate And Decanoate In Rat Peripheral Tissues: Evidence Of Bioenergetic Dysfunction And Oxidative Damage Induction In Liver And Skeletal Muscle. Mol Cell Biochem., 361, 329-335.
128. Song, Y., Selak, M.A., Watson, C.T., Coutts, C., Scherer, P.C., Panzer, J.A., Gibbs, S., Scott, M.O., Willer, G., Gregg, R.G., et al. (2009) Mechanisms Underlying Metabolic And Neural Defects In Zebrafish And Human Multiple Acyl-Coa Dehydrogenase Deficiency (MADD). Plos. One., 4, E8329.
129. Kim, S.H., Scott, S.A., Bennett, M.J., Carson, R.P., Fessel, J., Brown, H.A., Ess, K.C. (2013) Multi-Organ Abnormalities And Mtorc1 Activation In Zebrafish Model Of Multiple Acyl-Coa Dehydrogenase Deficiency. Plos. Genet, 9, E1003563.
130. Yuan, H.X., Xiong, Y., Guan, K.L. (2013) Nutrient Sensing, Metabolism, And Cell Growth Control. Mol Cell, 49, 379-387.
131. Sena, L.A., Chandel, N.S. (2012) Physiological Roles Of Mitochondrial Reactive Oxygen Species. Mol Cell, 48, 158-167.
132. Fischer, F., Hamann, A., Osiewacz, H.D. (2012) Mitochondrial Quality Control: An Integrated Network Of Pathways. Trends Biochem. Sci., 37, 284-292.
133. Zolkipli, Z., Pedersen, C.B., Lamhonwah, A.M., Gregersen, N., Tein, I. (2011) Vulnerability To Oxidative Stress In Vitro In Pathophysiology Of Mitochondrial Short-Chain Acyl-Coa Dehydrogenase Deficiency: Response To Antioxidants. Plos. One., 6, E17534.
134. Desquiret-Dumas, V., Gueguen, N., Leman, G., Baron, S., Nivet- Antoine, V., Chupin, S., Chevrollier, A., Vessieres, E., Ayer, A., Ferre, M., et al. (2013) Resveratrol Induces A Mitochondrial Complex IDependent Increase In NADH Oxidation Responsible For Sirtuin Activation In Liver Cells. J Biol. Chem., 288, 36662-36675.
135. Djouadi, F., Aubey, F., Schlemmer, D., Ruiter, J.P., Wanders, R.J., Strauss, A.W., Bastin, J. (2005) Bezafibrate Increases Very-Long-Chain Acyl-Coa Dehydrogenase Protein And Mrna Expression In Deficient Fibroblasts And Is A Potential Therapy For Fatty Acid Oxidation Disorders. Hum Mol Genet, 14, 2695-2703.
136. Bonnefont, J.P., Bastin, J., Behin, A., Djouadi, F. (2009) Bezafibrate For An Inborn Mitochondrial Beta-Oxidation Defect. N. Engl. J Med., 360, 838-840.
137. Yamaguchi, S., Li, H., Purevsuren, J., Yamada, K., Furui, M., Takahashi, T., Mushimoto, Y., Kobayashi, H., Hasegawa, Y., Taketani, T., et al. (2012) Bezafibrate Can Be A New Treatment Option For Mitochondrial Fatty Acid Oxidation Disorders: Evaluation By In Vitro Probe Acylcarnitine Assay. Mol Genet Metab, 107, 87-91.
138. Bastin, J., Lopes-Costa, A., Djouadi, F. (2011) Exposure To Resveratrol Triggers Pharmacological Correction Of Fatty Acid Utilization In Human Fatty Acid Oxidation-Deficient Fibroblasts. Hum Mol Genet, 20, 2048-2057.
139. Bonnefont, J.P., Bastin, J., Laforet, P., Aubey, F., Mogenet, A., Romano, S., Ricquier, D., Gobin-Limballe, S., Vassault, A., Behin, A., et al. (2010) Long-Term Follow-Up Of Bezafibrate Treatment In Patients With The Myopathic Form Of Carnitine Palmitoyltransferase 2 Deficiency. Clin. Pharmacol. Ther., 88, 101-108.
140. Orngreen, M.C., Madsen, K.L., Preisler, N., Andersen, G., Vissing, J., Laforet, P. (2014) Bezafibrate In Skeletal Muscle Fatty Acid Oxidation Disorders: A Randomized Clinical Trial. Neurology.
141. Lopes, C.A., Le, B.C., Mathieu, L., Rotig, A., Boneh, A., De, L.P., Tarnopolsky, M.A., Thorburn, D.R., Bastin, J., Djouadi, F. (2013) Beneficial Effects Of Resveratrol On Respiratory Chain Defects In Patients' Fibroblasts Involve Estrogen Receptor And Estrogen-Related Receptor Alpha Signaling. Hum Mol Genet.
142. Zhang, Z., Tsukikawa, M., Peng, M., Polyak, E., Nakamaru-Ogiso, E., Ostrovsky, J., Mccormack, S., Place, E., Clarke, C., Reiner, G., et al. (2013) Primary Respiratory Chain Disease Causes Tissue-Specific Dysregulation Of The Global Transcriptome And Nutrient-Sensing Signaling Network. Plos. One., 8, E69282.
143. Wakabayashi, M., Kamijo, Y., Nakajima, T., Tanaka, N., Sugiyama, E., Yangyang, T., Kimura, T., Aoyama, T. (2012) Fatty Acid Accumulation And Resulting Pparalpha Activation In Fibroblasts Due To Trifunctional Protein Deficiency. PPAR. Res., 2012, 371691.
144. Tucci, S., Herebian, D., Sturm, M., Seibt, A., Spiekerkoetter, U. (2012) Tissue-Specific Strategies Of The Very-Long Chain Acyl-Coa Dehydrogenase-Deficient (VLCAD-/-) Mouse To Compensate A Defective Fatty Acid Beta-Oxidation. Plos. One., 7, E45429.
145. Hoffmann, L., Seibt, A., Herebian, D., Spiekerkoetter, U. (2014) Monounsaturated 14:1n-9 And 16:1n-9 Fatty Acids But Not 18:1n-9 Induce Apoptosis And Necrosis In Murine HL-1 Cardiomyocytes. Lipids, 49, 25-37.
146. Sharma, L.K., Fang, H., Liu, J., Vartak, R., Deng, J., Bai, Y. (2011) Mitochondrial Respiratory Complex I Dysfunction Promotes Tumorigenesis Through ROS Alteration And AKT Activation. Hum Mol Genet, 20, 4605-4616.
147. Guo, J., Lemire, B.D. (2003) The Ubiquinone-Binding Site Of The Saccharomyces Cerevisiae Succinate-Ubiquinone Oxidoreductase Is A Source Of Superoxide. J Biol. Chem., 278, 47629-47635.
148. Huang, J., Lemire, B.D. (2009) Mutations In The C. Elegans Succinate Dehydrogenase Iron-Sulfur Subunit Promote Superoxide Generation And Premature Aging. J Mol Biol., 387, 559-569.
149. Maranzana, E., Barbero, G., Falasca, A.I., Lenaz, G., Genova, M.L. (2013) Mitochondrial Respiratory Supercomplex Association Limits Production Of Reactive Oxygen Species From Complex I. Antioxid. Redox. Signal.
150. Lopez-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J.M., Fabregat, I., Cacabelos, D., Boada, J., Martinez, J., Ferrer, I., Pamplona ,R., et al. (2013) Impaired Mitochondrial Oxidative Phosphorylation In The Peroxisomal Disease X-Linked Adrenoleukodystrophy. Hum Mol Genet, 22, 3296-3305.
151. Guzy, R.D., Sharma, B., Bell, E., Chandel, N.S., Schumacker, P.T. (2008) Loss Of The Sdhb, But Not The Sdha, Subunit Of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation And Tumorigenesis. Mol Cell Biol., 28, 718-731.
152. Schmitz-Hubsch, T., Klockgether, T. (2008) An Update On Inherited Ataxias. Curr. Neurol. Neurosci. Rep., 8, 310-319.
153. Embirucu, E.K., Martyn, M.L., Schlesinger, D., Kok, F. (2009) Autosomal Recessive Ataxias: 20 Types, And Counting. Arq Neuropsiquiatr., 67, 1143-1156.
154. Araujo, J., Breuer, P., Dieringer, S., Krauss, S., Dorn, S., Zimmermann, K., Pfeifer, A., Klockgether, T., Wuellner, U., Evert, B.O. (2011) FOXO4-Dependent Upregulation Of Superoxide Dismutase-2 In Response To Oxidative Stress Is Impaired In Spinocerebellar Ataxia Type 3. Hum. Mol. Genet., 20, 2928-2941.
155. Chen, P., Peng, C., Luff, J., Spring, K., Watters, D., Bottle, S., Furuya, S., Lavin, M.F. (2003) Oxidative Stress Is Responsible For Deficient Survival And Dendritogenesis In Purkinje Neurons From Ataxia- Telangiectasia Mutated Mutant Mice. J. Neurosci., 23, 11453-11460.
156. Pallardo, F.V., Lloret, A., Lebel, M., d'Ischia, M., Cogger, V.C., Le Couteur, D.G., Gadaleta, M.N., Castello, G., Pagano, G. (2010) Mitochondrial Dysfunction In Some Oxidative Stress-Related Genetic Diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi Anaemia And Werner Syndrome. Biogerontology., 11, 401-419.
157. Wang, Y.C., Lee, C.M., Lee, L.C., Tung, L.C., Hsieh-Li, H.M., Lee- Chen, G.J., Su, M.T. (2011) Mitochondrial Dysfunction And Oxidative Stress Contribute To The Pathogenesis Of Spinocerebellar Ataxia Type 12 (SCA12). J. Biol. Chem., 286, 21742-21754.
158. Watters, D.J. (2003) Oxidative Stress In Ataxia Telangiectasia. Redox. Rep., 8, 23-29.
159. Marmolino, D. (2011) Friedreich's Ataxia: Past, Present And Future. Brain Res. Rev., 67, 311-330.
160. Pandolfo, M. (2009) Introduction. Idebenone In The Treatment Of Friedreich Ataxia. J. Neurol., 256 Suppl 1, 1-2.
161. Campuzano, V., Montermini, L., Molto, M.D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) Friedreich's Ataxia: Autosomal Recessive Disease Caused By An Intronic GAA Triplet Repeat Expansion. Science, 271, 1423-1427.
162. Parkinson, M.H., Boesch, S., Nachbauer, W., Mariotti, C., Giunti P. (2013) Clinical Features Of Friedreich's Ataxia: Classical And Atypical Phenotypes. J. Neurochem., 126 Suppl 1, 103-117.
163. Schmucker, S., Puccio, H. (2010) Understanding The Molecular Mechanisms Of Friedreich's Ataxia To Develop Therapeutic Approaches. Hum. Mol. Genet., 19, R103-R110.
164. Martelli, A., Napierala, M., Puccio, H. (2012) Understanding The Genetic And Molecular Pathogenesis Of Friedreich's Ataxia Through Animal And Cellular Models. Dis. Model. Mech., 5, 165-176.
165. Babcock, M., De, S.D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., Kaplan, J. (1997) Regulation Of Mitochondrial Iron Accumulation By Yfh1p, A Putative Homolog Of Frataxin. Science, 276, 1709-1712.
166. Foury, F., Cazzalini, O. (1997) Deletion Of The Yeast Homologue Of The Human Gene Associated With Friedreich's Ataxia Elicits Iron Accumulation In Mitochondria. FEBS Lett., 411, 373-377.
167. Foury, F. (1999) Low Iron Concentration And Aconitase Deficiency In A Yeast Frataxin Homologue Deficient Strain. FEBS Lett., 456, 281- 284.
168. Gonzalez-Cabo, P., Bolinches-Amoros, A., Cabello, J., Ros, S., Moreno, S., Baylis, H.A., Palau, F., Vazquez-Manrique, R.P. (2011) Disruption Of The ATP-Binding Cassette B7 (ABTM-1/ABCB7) Induces Oxidative Stress And Premature Cell Death In Caenorhabditis Elegans. J. Biol. Chem., 286, 21304-21314.
169. Ramirez, R.L., Qian, J., Santambrogio, P., Levi, S., Koeppen, A.H. (2012) Relation Of Cytosolic Iron Excess To Cardiomyopathy Of Friedreich's Ataxia. Am. J. Cardiol., 110, 1820-1827.
170. Whitnall, M., Suryo, R.Y., Huang, M.L., Saletta, F., Lok, H.C., Gutierrez, L., Lazaro, F.J., Fleming, A.J., St Pierre, T.G., Mikhael, M.R., et al. (2012) Identification Of Nonferritin Mitochondrial Iron Deposits In A Mouse Model Of Friedreich Ataxia. Proc. Natl. Acad. Sci. U. S. A, 109, 20590-20595.
171. Muhlenhoff, U., Richhardt, N., Gerber, J., Lill, R. (2002) Characterization Of Iron-Sulfur Protein Assembly In Isolated Mitochondria. A Requirement For ATP, NADH, And Reduced Iron. J. Biol. Chem., 277, 29810-29816.
172. Duby, G., Foury, F., Ramazzotti, A., Herrmann, J., Lutz, T. (2002) A Non-Essential Function For Yeast Frataxin In Iron-Sulfur Cluster Assembly. Hum. Mol. Genet., 11, 2635-2643.
173. Gerber, J., Muhlenhoff, U., Lill, R. (2003) An Interaction Between Frataxin And Isu1/Nfs1 That Is Crucial For Fe/S Cluster Synthesis On Isu1. EMBO Rep., 4, 906-911.
174. Ramazzotti,A., Vanmansart,V., Foury,F. (2004) Mitochondrial Functional Interactions Between Frataxin And Isu1p, The Iron-Sulfur Cluster Scaffold Protein, In Saccharomyces Cerevisiae. FEBS Lett., 557, 215-220.
175. Shan, Y., Napoli, E., Cortopassi, G. (2007) Mitochondrial Frataxin Interacts With ISD11 Of The NFS1/ISCU Complex And Multiple Mitochondrial Chaperones. Hum. Mol. Genet., 16, 929-941.
176. Yoon, T., Cowan, J.A. (2003) Iron-Sulfur Cluster Biosynthesis. Characterization Of Frataxin As An Iron Donor For Assembly Of [2Fe- 2S] Clusters In ISU-Type Proteins. J. Am. Chem. Soc., 125, 6078-6084.
177. Shan, Y., Cortopassi, G. (2012) HSC20 Interacts With Frataxin And Is Involved In Iron-Sulfur Cluster Biogenesis And Iron Homeostasis. Hum. Mol. Genet., 21, 1457-1469.
178. Richardson, D.R., Lane, D.J., Becker, E.M., Huang, M.L., Whitnall, M., Suryo, R.Y., Sheftel, A.D., Ponka, P. (2010) Mitochondrial Iron Trafficking And The Integration Of Iron Metabolism Between The Mitochondrion And Cytosol. Proc. Natl. Acad. Sci. U. S. A, 107, 10775- 10782.
179. Lill, R., Kispal, G. (2000) Maturation Of Cellular Fe-S Proteins: An Essential Function Of Mitochondria. Trends Biochem. Sci., 25, 352-356.
180. Richardson, D.R., Ponka, P. (1997) The Molecular Mechanisms Of The Metabolism And Transport Of Iron In Normal And Neoplastic Cells. Biochim. Biophys. Acta, 1331, 1-40.
181. Ganz, T. (2007) Molecular Control Of Iron Transport. J. Am. Soc. Nephrol., 18, 394-400.
182. Yoon, T., Cowan, J.A. (2004) Frataxin-Mediated Iron Delivery To Ferrochelatase In The Final Step Of Heme Biosynthesis. J. Biol. Chem., 279, 25943-25946.
183. Schoenfeld, R.A., Napoli, E., Wong, A., Zhan, S., Reutenauer, L., Morin, D., Buckpitt, A.R., Taroni, F., Lonnerdal, B., Ristow, M., et al. (2005) Frataxin Deficiency Alters Heme Pathway Transcripts And Decreases Mitochondrial Heme Metabolites In Mammalian Cells. Hum. Mol. Genet., 14, 3787-3799.
184. Lu, C., Cortopassi, G. (2007) Frataxin Knockdown Causes Loss Of Cytoplasmic Iron-Sulfur Cluster Functions, Redox Alterations And Induction Of Heme Transcripts. Arch. Biochem. Biophys., 457, 111-122.
185. Lill, R. (2009) Function And Biogenesis Of Iron-Sulphur Proteins. Nature, 460, 831-838.
186. Gerber, J., Lill, R. (2002) Biogenesis Of Iron-Sulfur Proteins In Eukaryotes: Components, Mechanism And Pathology. Mitochondrion., 2, 71-86.
187. Horowitz, M.P., Greenamyre, J.T. (2010) Mitochondrial Iron Metabolism And Its Role In Neurodegeneration. J. Alzheimers. Dis., 20 Suppl 2, S551-S568.
188. Bradley, J.L., Blake, J.C., Chamberlain, S., Thomas, P.K., Cooper, J.M., Schapira, A.H. (2000) Clinical, Biochemical And Molecular Genetic Correlations In Friedreich's Ataxia. Hum. Mol. Genet., 9, 275-282.
189. Rotig, A., De, L.P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., Rustin, P. (1997) Aconitase And Mitochondrial Iron- Sulphur Protein Deficiency In Friedreich Ataxia. Nat. Genet., 17, 215- 217.
190. Gonzalez-Cabo, P., Vazquez-Manrique, P., Garcia-Gimeno, M.A., Sanz, P., Palau, F. (2005) Frataxin Interacts Functionally With Mitochondrial Electron Transport Chain Proteins. Hum. Mol. Genet., 14, 2091-2098.
191. Vazquez-Manrique, R.P., Gonzalez-Cabo, P., Ros, S., Aziz, H., Baylis, H.A., Palau, F. (2006) Reduction Of Caenorhabditis Elegans Frataxin Increases Sensitivity To Oxidative Stress, Reduces Lifespan, And Causes Lethality In A Mitochondrial Complex II Mutant. FASEB J., 20, 172-174.
192. Wagner, G.R., Pride, P.M., Babbey, C.M., Payne, R.M. (2012) Friedreich's Ataxia Reveals A Mechanism For Coordinate Regulation Of Oxidative Metabolism Via Feedback Inhibition Of The SIRT3 Deacetylase. Hum. Mol. Genet., 21, 2688-2697.
193. Weir, H.J., Lane, J.D., Balthasar, N. (2013) SIRT3: A Central Regulator Of Mitochondrial Adaptation In Health And Disease. Genes Cancer, 4, 118-124.
194. Krebs, H.A., Veech, R.L. (1969) Equilibrium Relations Between Pyridine Nucleotides And Adenine Nucleotides And Their Roles In The Regulation Of Metabolic Processes. Adv. Enzyme Regul., 7, 397-413.
195. Ventura-Clapier, R., Garnier, A., Veksler, V. (2004) Energy Metabolism In Heart Failure. J. Physiol, 555, 1-13.
196. Hafner, A.V., Dai,J., Gomes, A.P., Xiao, C.Y., Palmeira, C.M., Rosenzweig, A., Sinclair, D.A. (2010) Regulation Of The Mptp By SIRT3-Mediated Deacetylation Of Cypd At Lysine 166 Suppresses Age- Related Cardiac Hypertrophy. Aging (Albany. NY), 2, 914-923.
197. Bause, A.S., Haigis, M.C. (2013) SIRT3 Regulation Of Mitochondrial Oxidative Stress. Exp. Gerontol., 48, 634-639.
198. Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K.L., Zhao, S., Xiong, Y. (2011) Tumour Suppressor SIRT3 Deacetylates And Activates Manganese Superoxide Dismutase To Scavenge ROS. EMBO Rep., 12, 534-541.
199. Qiu, X., Brown, K., Hirschey, M.D., Verdin, E., Chen, D. (2010) Calorie Restriction Reduces Oxidative Stress By SIRT3-Mediated SOD2 Activation. Cell Metab, 12, 662-667.
200. Tao, R., Coleman, M.C., Pennington, J.D., Ozden, O., Park, S.H., Jiang, H., Kim, H.S., Flynn, C.R., Hill, S., Hayes, M.W., et al. (2010) Sirt3- Mediated Deacetylation Of Evolutionarily Conserved Lysine 122 Regulates Mnsod Activity In Response To Stress. Mol. Cell, 40, 893- 904.
201. Bradley, J.L., Blake, J.C., Chamberlain, S., Thomas, P.K., Cooper, J.M., Schapira, A.H. (2000) Clinical, Biochemical And Molecular Genetic Correlations In Friedreich's Ataxia. Hum. Mol. Genet., 9, 275-282.
202. Al-Mahdawi, S., Pinto, R.M., Varshney, D., Lawrence, L., Lowrie, M.B., Hughes, S., Webster, Z., Blake, J., Cooper, J.M., King, R., Pook, M.A. (2006) GAA Repeat Expansion Mutation Mouse Models Of Friedreich Ataxia Exhibit Oxidative Stress Leading To Progressive Neuronal And Cardiac Pathology. Genomics, 88, 580-590.
203. Yan, L.J., Levine, R.L., Sohal, R.S. (1997) Oxidative Damage During Aging Targets Mitochondrial Aconitase. Proc. Natl. Acad. Sci. U. S. A, 94, 11168-11172.
204. Llorens, J.V., Navarro, J.A., Martinez-Sebastian, M.J., Baylies, M.K., Schneuwly, S., Botella, J.A., Molto, M.D. (2007) Causative Role Of Oxidative Stress In A Drosophila Model Of Friedreich Ataxia. FASEB J., 21, 333-344.
205. Swarup, V., Srivastava, A.K., Padma, M.V., Rajeswari, M.R. (2013) Quantitative Profiling And Identification Of Differentially Expressed Plasma Proteins In Friedreich's Ataxia. J. Neurosci. Res., 91, 1483-1491.
206. Schiavi, A., Torgovnick, A., Kell, A., Megalou, E., Castelein, N., Guccini, I., Marzocchella, L., Gelino, S., Hansen, M., Malisan, F., et al. (2013) Autophagy Induction Extends Lifespan And Reduces Lipid Content In Response To Frataxin Silencing In C. Elegans. Exp. Gerontol., 48, 191-201.
207. Navarro, J.A., Ohmann, E., Sanchez, D., Botella, J.A., Liebisch, G., Molto, M.D., Ganfornina,M.D., Schmitz,G., Schneuwly,S. (2010) Altered Lipid Metabolism In A Drosophila Model Of Friedreich's Ataxia. Hum. Mol. Genet., 19, 2828-2840.
208. Ross, B.M., Eder, K., Moszczynska, A., Mamalias, N., Lamarche, J., Ang, L., Pandolfo, M., Rouleau, G., Kirchgessner, M., Kish, S.J. (2000) Abnormal Activity Of Membrane Phospholipid Synthetic Enzymes In The Brain Of Patients With Friedreich's Ataxia And Spinocerebellar Atrophy Type-1. Mov Disord., 15, 294-300.
209. Eder, K., Kish, S.J., Kirchgessner, M., Ross ,B.M. (1998) Brain Phospholipids And Fatty Acids In Friedreich's Ataxia And Spinocerebellar Atrophy Type-1. Mov Disord., 13, 813-819.
210. Feki, M., Belal, S., Feki, H., Souissi, M., Frih-Ayed, M., Kaabachi, N., Hentati, F., Ben, H.M., Mebazaa, A. (2002) Serum Vitamin E And Lipid-Adjusted Vitamin E Assessment In Friedreich Ataxia Phenotype Patients And Unaffected Family Members. Clin. Chem., 48, 577-579.
211. Iorio, L., De, M.G., Filla, A., Di, M.L., Postiglione, A., Patti, L., Campanella, G. (1993) Serum Lipoprotein Fatty Acid Profile In Hereditary Ataxias. Can. J. Neurol. Sci., 20, 206-209.
212. Puccio, H., Simon, D., Cossee, M., Criqui-Filipe, P., Tiziano,F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., Koenig, M. (2001) Mouse Models For Friedreich Ataxia Exhibit Cardiomyopathy, Sensory Nerve Defect And Fe-S Enzyme Deficiency Followed By Intramitochondrial Iron Deposits. Nat. Genet., 27, 181-186.
213. Adibhatla, R.M., Hatcher, J.F. (2008) Altered Lipid Metabolism In Brain Injury And Disorders. Subcell. Biochem., 49, 241-268.
214. Shoichet, S.A., Baumer, A.T., Stamenkovic, D., Sauer, H., Pfeiffer, A.F., Kahn, C.R., Muller-Wieland, D., Richter, C., Ristow, M. (2002) Frataxin Promotes Antioxidant Defense In A Thiol-Dependent Manner Resulting In Diminished Malignant Transformation In Vitro. Hum. Mol. Genet., 11, 815-821.
215. Piemonte, F., Pastore, A., Tozzi, G., Tagliacozzi, D., Santorelli, F.M., Carrozzo, R., Casali, C., Damiano, M., Federici, G., Bertini, E. (2001) Glutathione In Blood Of Patients With Friedreich's Ataxia. Eur. J. Clin. Invest, 31, 1007-1011.
216. Paupe, V., Dassa, E.P., Goncalves, S., Auchere, F., Lonn, M., Holmgren, A., Rustin, P. (2009) Impaired Nuclear Nrf2 Translocation Undermines The Oxidative Stress Response In Friedreich Ataxia. Plos. One., 4, E4253.
217. Jiralerspong, S., Ge, B., Hudson, T.J., Pandolfo, M. (2001) Manganese Superoxide Dismutase Induction By Iron Is Impaired In Friedreich Ataxia Cells. FEBS Lett., 509, 101-105.
218. Warner, B.B., Stuart, L., Gebb, S., Wispe, J.R. (1996) Redox Regulation Of Manganese Superoxide Dismutase. Am. J. Physiol, 271, L150-L158.
219. Kiningham, K.K., Xu, Y., Daosukho, C., Popova, B., St Clair, D.K. (2001) Nuclear Factor Kappab-Dependent Mechanisms Coordinate The Synergistic Effect Of PMA And Cytokines On The Induction Of Superoxide Dismutase 2. Biochem. J., 353, 147-156.
220. Shi, X., Dong, Z., Huang, C., Ma, W., Liu, K., Ye, J., Chen, F., Leonard, S.S., Ding, M., Castranova, V., Vallyathan, V. (1999) The Role Of Hydroxyl Radical As A Messenger In The Activation Of Nuclear Transcription Factor NF-Kappab. Mol. Cell Biochem., 194, 63-70.
221. Busi, M.V., Maliandi, M.V., Valdez, H., Clemente, M., Zabaleta, E.J., Araya, A., Gomez-Casati, D.F. (2006) Deficiency Of Arabidopsis Thaliana Frataxin Alters Activity Of Mitochondrial Fe-S Proteins And Induces Oxidative Stress. Plant J., 48, 873-882.
222. Emond, M., Lepage, G., Vanasse, M., Pandolfo, M. (2000) Increased Levels Of Plasma Malondialdehyde In Friedreich Ataxia. Neurology, 55, 1752-1753.
223. Bradley, J.L., Homayoun, S., Hart, P.E., Schapira, A.H., Cooper, J.M. (2004) Role Of Oxidative Damage In Friedreich's Ataxia. Neurochem. Res., 29, 561-567.
224. Santos, M.M., Ohshima, K., Pandolfo, M. (2001) Frataxin Deficiency Enhances Apoptosis In Cells Differentiating Into Neuroectoderm. Hum. Mol. Genet., 10, 1935-1944.
225. Irazusta, V., Cabiscol, E., Reverter-Branch, Ros, J., Tamarit, J. (2006) Manganese Is The Link Between Frataxin And Iron-Sulfur Deficiency In The Yeast Model Of Friedreich Ataxia. J. Biol. Chem., 281, 12227- 12232.
226. Napoli, E., Taroni, F., Cortopassi, G.A. (2006) Frataxin, Iron-Sulfur Clusters, Heme, ROS, And Aging. Antioxid. Redox. Signal., 8, 506-516.
227. Seguin, A., Bayot, A., Dancis, A., Rogowska-Wrzesinska,A., Auchere, F., Camadro, J.M., Bulteau, A.L., Lesuisse, E. (2009) Overexpression Of The Yeast Frataxin Homolog (Yfh1): Contrasting Effects On Iron-Sulfur Cluster Assembly, Heme Synthesis And Resistance To Oxidative Stress. Mitochondrion., 9, 130-138.
228. Chantrel-Groussard, K., Geromel, V., Puccio, H., Koenig, M., Munnich, A., Rotig, A., Rustin, P. (2001) Disabled Early Recruitment Of Antioxidant Defenses In Friedreich's Ataxia. Hum. Mol. Genet., 10, 2061-2067.
229. Jiralerspong, S., Ge, B., Hudson, T.J., Pandolfo, M. (2001) Manganese Superoxide Dismutase Induction By Iron Is Impaired In Friedreich Ataxia Cells. FEBS Lett., 509, 101-105.
230. Lin, J., Handschin, C., Spiegelman, B.M. (2005) Metabolic Control Through The PGC-1 Family Of Transcription Coactivators. Cell Metab, 1, 361-370.
231. Garcia-Gimenez, J.L., Gimeno, A., Gonzalez-Cabo, P., Dasi, F., Bolinches-Amoros, A., Molla, B., Palau, F., Pallardo, F.V. (2011) Differential Expression Of PGC-1alpha And Metabolic Sensors Suggest Age-Dependent Induction Of Mitochondrial Biogenesis In Friedreich Ataxia Fibroblasts. Plos. One., 6, E20666.
232. Moreira, P.I., Santos, M.S., Oliveira, C.R. (2007) Alzheimer's Disease: A Lesson From Mitochondrial Dysfunction. Antioxid. Redox. Signal., 9, 1621-1630.
233. Finkel, T. (2005) Radical Medicine: Treating Ageing To Cure Disease. Nat. Rev. Mol. Cell Biol., 6, 971-976.
234. Gruber, J., Fong, S., Chen, C.B., Yoong, S., Pastorin, G., Schaffer, S., Cheah, I., Halliwell ,B. (2013) Mitochondria-Targeted Antioxidants And Metabolic Modulators As Pharmacological Interventions To Slow Ageing. Biotechnol. Adv., 31, 563-592.
235. Moreira, P.I., Zhu, X., Wang, X., Lee, H.G., Nunomura, A., Petersen, R.B., Perry, G., Smith, M.A. (2010) Mitochondria: A Therapeutic Target In Neurodegeneration. Biochim. Biophys. Acta, 1802, 212-220.
236. Wallimann, T., Tokarska-Schlattner, M., Schlattner, U. (2011) The Creatine Kinase System And Pleiotropic Effects Of Creatine. Amino. Acids, 40, 1271-1296.
237. Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., Eppenberger, H.M. (1992) Intracellular Compartmentation, Structure And Function Of Creatine Kinase Isoenzymes In Tissues With High And Fluctuating Energy Demands: The 'Phosphocreatine Circuit' For Cellular Energy Homeostasis. Biochem. J., 281 (Pt 1), 21-40.
238. Bessman, S.P., Geiger, P.J. (1981) Transport Of Energy In Muscle: The Phosphorylcreatine Shuttle. Science, 211, 448-452.
239. O'Gorman, E., Beutner, G., Dolder, M., Koretsky, A.P., Brdiczka, D., Wallimann, T. (1997) The Role Of Creatine Kinase In Inhibition Of Mitochondrial Permeability Transition. FEBS Lett., 414, 253-257.
240. Andres, R.H., Ducray, A.D., Perez-Bouza, A., Schlattner, U., Huber, A.W., Krebs, S.H., Seiler, R.W., Wallimann, T., Widmer, H.R. (2005) Creatine Supplementation Improves Dopaminergic Cell Survival And Protects Against MPP+ Toxicity In An Organotypic Tissue Culture System. Cell Transplant., 14, 537-550.
241. Andres, R.H., Ducray, A.D., Huber, A.W., Perez-Bouza, A., Krebs, S.H., Schlattner, U., Seiler, R.W., Wallimann, T., Widmer, H.R. (2005) Effects Of Creatine Treatment On Survival And Differentiation Of GABA-Ergic Neurons In Cultured Striatal Tissue. J. Neurochem., 95, 33-45.
242. Andres, R.H., Huber, A.W., Schlattner, U., Perez-Bouza, A., Krebs, S.H., Seiler, R.W., Wallimann, T., Widmer, H.R. (2005) Effects Of Creatine Treatment On The Survival Of Dopaminergic Neurons In Cultured Fetal Ventral Mesencephalic Tissue. Neuroscience, 133, 701- 713.
243. Hersch, S.M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., et al. (2006) Creatine In Huntington Disease Is Safe, Tolerable, Bioavailable In Brain And Reduces Serum 8OH2'dG. Neurology, 66, 250-252.
244. Reiter, R.J. (1991) Melatonin: The Chemical Expression Of Darkness. Mol. Cell Endocrinol., 79, C153-C158.
245. Tan, D.X., Hardeland, R., Manchester, L.C., Galano, A., Reiter, R.J. (2013) Cyclic-3-Hydroxymelatonin (C3HOM), A Potent Antioxidant, Scavenges Free Radicals And Suppresses Oxidative Reactions. Curr. Med. Chem.
246. Poeggeler, B., Saarela, S., Reiter, R.J., Tan, D.X., Chen, L.D., Manchester, L.C., Barlow-Walden, L.R. (1994) Melatonin--A Highly Potent Endogenous Radical Scavenger And Electron Donor: New Aspects Of The Oxidation Chemistry Of This Indole Accessed In Vitro. Ann. N. Y. Acad. Sci., 738, 419-420.
247. Rosales-Corral, S.A., Acuna-Castroviejo, D., Coto-Montes, A., Boga, J.A., Manchester, L.C., Fuentes-Broto, L., Korkmaz, A., Ma, S., Tan, D.X., Reiter, R.J. (2012) Alzheimer's Disease: Pathological Mechanisms And The Beneficial Role Of Melatonin. J. Pineal Res., 52, 167-202.
248. Cheng, Y., Feng, Z., Zhang, Q.Z., Zhang, J.T. (2006) Beneficial Effects Of Melatonin In Experimental Models Of Alzheimer Disease. Acta Pharmacol. Sin., 27, 129-139.
249. Feng, Z., Chang, Y., Cheng, Y., Zhang, B.L., Qu, Z.W., Qin, C., Zhang, J.T. (2004) Melatonin Alleviates Behavioral Deficits Associated With Apoptosis And Cholinergic System Dysfunction In The APP 695 Transgenic Mouse Model Of Alzheimer's Disease. J. Pineal Res., 37, 129-136.
250. Pohanka, M., Bandouchova, H., Pikula, J. (2012) Melatonin Influences Antioxidant Homeostasis And Basal Metabolism In The BALB/C Mouse Model. Neuro. Endocrinol. Lett., 33 Suppl 3, 183-189.
251. Wang, X. (2009) The Antiapoptotic Activity Of Melatonin In Neurodegenerative Diseases. CNS. Neurosci. Ther., 15, 345-357.
252. Acuna-Castroviejo, D., Martin, M., Macias, M., Escames, G., Leon, J., Khaldy, H., Reiter, R.J. (2001) Melatonin, Mitochondria, And Cellular Bioenergetics. J. Pineal Res., 30, 65-74.
253. Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., Vohra, S., Klassen, T.P., Baker, G. (2006) Efficacy And Safety Of Exogenous Melatonin For Secondary Sleep Disorders And Sleep Disorders Accompanying Sleep Restriction: Meta-Analysis. BMJ, 332, 385-393.
254. Orsucci, D., Mancuso, M., Ienco, E.C., Logerfo, A., Siciliano, G. (2011) Targeting Mitochondrial Dysfunction And Neurodegeneration By Means Of Coenzyme Q10 And Its Analogues. Curr. Med. Chem., 18, 4053- 4064.
255. Hargreaves, I.P. (2003) Ubiquinone: Cholesterol's Reclusive Cousin. Ann. Clin. Biochem., 40, 207-218.
256. Lenaz, G., Fato, R., Formiggini, G., Genova, M.L. (2007) The Role Of Coenzyme Q In Mitochondrial Electron Transport. Mitochondrion., 7 Suppl, S8-33.
257. Kooncumchoo, P., Sharma, S., Porter, J., Govitrapong, P., Ebadi, M. (2006) Coenzyme Q(10) Provides Neuroprotection In Iron-Induced Apoptosis In Dopaminergic Neurons. J. Mol. Neurosci., 28, 125-141.
258. Somayajulu, M., Mccarthy, S., Hung, M., Sikorska, M., Borowy- Borowski, H., Pandey, S. (2005) Role Of Mitochondria In Neuronal Cell Death Induced By Oxidative Stress; Neuroprotection By Coenzyme Q10. Neurobiol. Dis., 18, 618-627.
259. Yang, X., Yang, Y., Li, G., Wang, J., Yang, E.S. (2008) Coenzyme Q10 Attenuates Beta-Amyloid Pathology In The Aged Transgenic Mice With Alzheimer Presenilin 1 Mutation. J. Mol. Neurosci., 34, 165-171.
260. Bhagavan, H.N., Chopra, R.K. (2006) Coenzyme Q10: Absorption, Tissue Uptake, Metabolism And Pharmacokinetics. Free Radic. Res., 40, 445-453.
261. Meier, T., Buyse, G. (2009) Idebenone: An Emerging Therapy For Friedreich Ataxia. J. Neurol., 256 Suppl 1, 25-30.
262. Rustin, P., Von Kleist-Retzow, J.C., Chantrel-Groussard, K., Sidi, D., Munnich, A., Rotig, A. (1999) Effect Of Idebenone On Cardiomyopathy In Friedreich's Ataxia: A Preliminary Study. Lancet, 354, 477-479.
263. Artuch, R., Aracil, A., Mas, A., Colome, C., Rissech, M., Monros ,E., Pineda, M. (2002) Friedreich's Ataxia: Idebenone Treatment In Early Stage Patients. Neuropediatrics, 33, 190-193.
264. Schulz, J.B., Dehmer, T., Schols, L., Mende, H., Hardt, C., Vorgerd, M., Burk, K., Matson, W., Dichgans, J., Beal, M.F., Bogdanov ,M.B. (2000) Oxidative Stress In Patients With Friedreich Ataxia. Neurology, 55, 1719-1721.
265. Di Prospero, N.A., Baker, A., Jeffries, N., Fischbeck, K.H. (2007) Neurological Effects Of High-Dose Idebenone In Patients With Friedreich's Ataxia: A Randomised, Placebo-Controlled Trial. Lancet Neurol., 6, 878-886.
266. Murphy, M.P., Smith, R.A. (2000) Drug Delivery To Mitochondria: The Key To Mitochondrial Medicine. Adv. Drug Deliv. Rev., 41, 235-250.
267. Smith, R.A., Porteous, C.M., Coulter, C.V., Murphy, M.P. (1999) Selective Targeting Of An Antioxidant To Mitochondria. Eur. J. Biochem., 263, 709-716.
268. Asin-Cayuela, J., Manas, A.R., James, A.M., Smith, R.A., Murphy, M.P. (2004) Fine-Tuning The Hydrophobicity Of A Mitochondria-Targeted Antioxidant. FEBS Lett., 571, 9-16.
269. James, A.M., Cocheme, H.M., Murphy, M.P. (2005) Mitochondria- Targeted Redox Probes As Tools In The Study Of Oxidative Damage And Ageing. Mech. Ageing Dev., 126, 982-986.
270. Kelso, G.F., Porteous, C.M., Coulter, C.V., Hughes, G., Porteous, W.K., Ledgerwood, E.C., Smith, R.A., Murphy, M.P. (2001) Selective Targeting Of A Redox-Active Ubiquinone To Mitochondria Within Cells: Antioxidant And Antiapoptotic Properties. J. Biol. Chem., 276, 4588-4596.
271. Hughes, G., Murphy, M.P., Ledgerwood, E.C. (2005) Mitochondrial Reactive Oxygen Species Regulate The Temporal Activation Of Nuclear Factor Kappab To Modulate Tumour Necrosis Factor-Induced Apoptosis: Evidence From Mitochondria-Targeted Antioxidants. Biochem. J., 389, 83-89.
272. Hart, P.E., Lodi, R., Rajagopalan, B., Bradley, J.L., Crilley, J.G., Turner, C., Blamire, A.M., Manners, D., Styles, P., Schapira, A.H., Cooper, J.M. (2005) Antioxidant Treatment Of Patients With Friedreich Ataxia: Four- Year Follow-Up. Arch. Neurol., 62, 621-626.
273. Szeto, H.H. (2006) Cell-Permeable, Mitochondrial-Targeted, Peptide Antioxidants. AAPS. J., 8, E277-E283.
274. Zhao, K., Zhao, G.M., Wu, D., Soong, Y., Birk, A.V., Schiller, P.W., Szeto, H.H. (2004) Cell-Permeable Peptide Antioxidants Targeted To Inner Mitochondrial Membrane Inhibit Mitochondrial Swelling, Oxidative Cell Death, And Reperfusion Injury. J. Biol. Chem., 279, 34682-34690.
275. Szeto, H.H. (2008) Development Of Mitochondria-Targeted Aromatic- Cationic Peptides For Neurodegenerative Diseases. Ann. N. Y. Acad. Sci., 1147, 112-121.
276. Szeto, H.H. (2008) Mitochondria-Targeted Cytoprotective Peptides For Ischemia-Reperfusion Injury. Antioxid. Redox. Signal., 10, 601-619.
277. Calkins, M.J., Johnson, D.A., Townsend, J.A., Vargas, M.R., Dowell, J.A., Williamson, T.P., Kraft, A.D., Lee, J.M., Li, J., Johnson, J.A. (2009) The Nrf2/ARE Pathway As A Potential Therapeutic Target In Neurodegenerative Disease. Antioxid. Redox. Signal., 11, 497-508.
278. Joshi, G., Johnson, J.A. (2012) The Nrf2-ARE Pathway: A Valuable Therapeutic Target For The Treatment Of Neurodegenerative Diseases. Recent Pat CNS. Drug Discov., 7, 218-229.
279. Honda, T., Rounds, B.V., Bore, L., Finlay, H.J., Favaloro, F.G., Jr., Suh, N., Wang, Y., Sporn, M.B., Gribble, G.W. (2000) Synthetic Oleanane And Ursane Triterpenoids With Modified Rings A And C: A Series Of Highly Active Inhibitors Of Nitric Oxide Production In Mouse Macrophages. J. Med. Chem., 43, 4233-4246.
280. Dinkova-Kostova, A.T., Liby, K.T., Stephenson, K.K., Holtzclaw, W.D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G.W., et al. (2005) Extremely Potent Triterpenoid Inducers Of The Phase 2 Response: Correlations Of Protection Against Oxidant And Inflammatory Stress. Proc. Natl. Acad. Sci. U. S. A, 102, 4584-4589.
281. Sporn, M.B., Liby, K.T., Yore, M.M., Fu, L., Lopchuk, J.M., Gribble, G.W. (2011) New Synthetic Triterpenoids: Potent Agents For Prevention And Treatment Of Tissue Injury Caused By Inflammatory And Oxidative Stress. J. Nat. Prod., 74, 537-545.